A major discovery in cancer study is occurring with the use of nanobodies to restore dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in various types of tumors, leading uncontrolled https://bookmark-nation.com/story21762245/mini-antibodies-reactivate-tumor-suppressor-p53-a-potential-approach-for-cancer-management